한글목차

뇌졸중 관리 동향과 예측

세계의 뇌졸중 관리 시장은 2024년부터 2030년까지 CAGR이 8.5%로, 2030년까지 약 651억 4,000만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 성장 촉진요인은 고령화 진행, 관상동맥성 심질환과 고혈압에 시달리는 사람 수 증가 및 뇌졸중 진단 방법 기술 진보입니다. 세계의 뇌졸중 관리 시장의 미래는 허혈성 뇌졸중 및 출혈성 뇌졸중 시장에서의 기회로 인해 유망해 보입니다.

뇌졸중 관리 시장에 관한 인사이트

Lucintel은 뇌졸중 질환 조기 진단에 관한 일반 지식 증가에 의한 뇌졸중 진단 증가에 의해 진단이 예측기간 중 가장 높은 성장을 이룰 것으로 예상하고 있습니다.

아시아태평양은 헬스케어비 증가와 가처분 소득 증가에 의해 예측기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

자주 묻는 질문

Q1. 뇌졸중 관리 시장 규모는 어느 정도인가?

A1. 세계의 뇌졸중 관리 시장은 2030년까지 약 651억 4,000만 달러에 달할 것으로 예상됩니다.

Q2. 뇌졸중 관리 시장 성장 예측은 무엇인가?

A2. 세계의 뇌졸중 관리 시장은 2024년부터 2030년까지 8.5%의 CAGR로 성장할 것으로 예상됩니다.

Q3. 뇌졸중 관리 시장의 성장에 영향을 미치는 주요 요인은 무엇인가?

A3. 이 시장의 주요 성장 촉진요인은 고령화 진행, 관상동맥성 심질환이나 고혈압에 시달리는 사람 수 증가, 뇌졸중 진단 방법 기술 진보입니다.

Q4. 시장의 주요 부문은?

A4. 뇌졸중 관리 시장의 미래는 허혈성 뇌졸중 및 출혈성 뇌졸중 시장에서의 기회로 인해 유망해 보입니다.

Q5. 시장의 주요 기업은?

A5. 주요 뇌졸중 관리 회사는 다음과 같습니다.

• B Braun Melsungen
• Cardinal Health
• Medtronic
• Bristol Myers Squibb
• Boston Scientific Corporation
• Abbott Laboratories
• General Electric Company
• Merck
• Siemens
• Glaxosmithkline

Q6. 향후 최대가 되는 시장 부문은?

A6. Lucintel은 뇌졸중 질환 조기 진단에 관한 일반 지식 증가에 의한 뇌졸중 진단 증가에 의해 진단이 예측기간 중 가장 높은 성장을 이룰 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?

A7. 아시아태평양은 헬스케어비 증가와 가처분 소득 증가에 의해 예측기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 뇌졸중 관리 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 뇌졸중 관리 시장 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 세계의 뇌졸중 관리 시장
  • 진단
  • 치료
  • 소프트웨어
• 용도별 세계의 뇌졸중 관리 시장
  • 허혈성 뇌졸중
  • 출혈성 뇌졸중

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 뇌졸중 관리 시장
• 북미의 뇌졸중 관리 시장
• 유럽의 뇌졸중 관리 시장
• 아시아태평양의 뇌졸중 관리 시장
• 기타 지역의 뇌졸중 관리 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 뇌졸중 관리 시장 성장 기회
  • 용도별 세계의 뇌졸중 관리 시장 성장 기회
  • 지역별 세계의 뇌졸중 관리 시장 성장 기회
• 세계의 뇌졸중 관리 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 뇌졸중 관리 시장 능력 확대
  • 세계의 뇌졸중 관리 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• B Braun
• Cardinal Health
• Medtronic
• Bristol Myers Squibb
• Boston Scientific Corporation
• Abbott Laboratories
• General Electric Company
• Merck
• Siemens
• NeuraSignal

영문목차

Stroke Management Trends and Forecast

The future of the global stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets. The global stroke management market is expected to reach an estimated $65.14 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

A more than 150-page report is developed to help in your business decisions.

Stroke Management by Segment

The study includes a forecast for the global stroke management by type, application, and region.

Stroke Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostics
• Therapeutics
• Software

Stroke Management Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Ischemic Stroke
• Hemorrhagic Stroke

Stroke Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Stroke Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stroke management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stroke management companies profiled in this report include-

• B Braun
• Cardinal Health
• Medtronic
• Bristol Myers Squibb
• Boston Scientific Corporation
• Abbott Laboratories
• General Electric Company
• Merck
• Siemens
• Neurasignal

Stroke Management Market Insights

Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Features of the Global Stroke Management Market

Market Size Estimates: Stroke management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stroke management market size by type, application, and region in terms of value ($B).

Regional Analysis: Stroke management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the stroke management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stroke management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stroke management market size?

Answer: The global stroke management market is expected to reach an estimated $65.14 billion by 2030.

Q.2 What is the growth forecast for stroke management market?

Answer: The global stroke management market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stroke management market?

Answer: The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

Q4. What are the major segments for stroke management market?

Answer: The future of the stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets.

Q5. Who are the key stroke management market companies?

Answer: Some of the key stroke management companies are as follows.

• B Braun Melsungen
• Cardinal Health
• Medtronic
• Bristol Myers Squibb
• Boston Scientific Corporation
• Abbott Laboratories
• General Electric Company
• Merck
• Siemens
• Glaxosmithkline

Q6. Which stroke management market segment will be the largest in future?

Answer: Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

Q7. In stroke management market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the stroke management market by type (diagnostics and therapeutics), application (ischemic stroke and hemorrhagic stroke), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stroke Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Stroke Management Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Stroke Management Market by Type
  • 3.3.1: Diagnostics
  • 3.3.2: Therapeutics
  • 3.3.3: Software
• 3.4: Global Stroke Management Market by Application
  • 3.4.1: Ischemic Stroke
  • 3.4.2: Hemorrhagic Stroke

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Stroke Management Market by Region
• 4.2: North American Stroke Management Market
  • 4.2.2: North American Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
• 4.3: European Stroke Management Market
  • 4.3.1: European Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
  • 4.3.2: European Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
• 4.4: APAC Stroke Management Market
  • 4.4.1: APAC Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
  • 4.4.2: APAC Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
• 4.5: ROW Stroke Management Market
  • 4.5.1: ROW Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
  • 4.5.2: ROW Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Stroke Management Market by Type
  • 6.1.2: Growth Opportunities for the Global Stroke Management Market by Application
  • 6.1.3: Growth Opportunities for the Global Stroke Management Market by Region
• 6.2: Emerging Trends in the Global Stroke Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Stroke Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stroke Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: B Braun
• 7.2: Cardinal Health
• 7.3: Medtronic
• 7.4: Bristol Myers Squibb
• 7.5: Boston Scientific Corporation
• 7.6: Abbott Laboratories
• 7.7: General Electric Company
• 7.8: Merck
• 7.9: Siemens
• 7.10: NeuraSignal